The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don’t have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).
UTEP launches clinical trial to improve community health through walking
Health researchers at The University of Texas at El Paso are launching a clinical trial to improve walking in the El Paso community, thanks to
March 6, 2024